Generic medicine
Dextrose
Dextrose · Fluids & supportive care · Fluids, electrolytes & diluents
Data statusRegistration & price fields require source verification.
82brands/products
17companies
82with current prices
Available dosage forms
Tap a form to filter the brand listChoose a form
Pakistan brand index
Available brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price | Unit price |
|---|---|---|---|---|---|---|---|
| Solvein-Iso | MS SIZA INTERNATIONAL PVT LTD. | 5.61 g + 0.24 g + 0.15 g + 10.08 g (50% solution) + 16.5 g / 1000 mL | IV infusion | 1000 ml | 015638 | PKR 132.492026-07-27 | PKR 0.13/ mL |
| Sterifluid | FRONTIER DEXTROSE LIMITED | 5 % | IV infusion | 100ml | 056329 | PKR 87.522026-07-27 | PKR 0.88/ mL |
| Sterifluid | FRONTIER DEXTROSE LIMITED | 25% | IV infusion | 1000ml | 056328 | PKR 183.782026-07-27 | PKR 0.18/ mL |
| Unilyte-M | Unisa Pharmaceutical Industries Limited | 0.022 g + 0.150 g + 0.216 g + 0.313 g + 5 g / 100 mL | IV infusion | 1000 ml | 079523 | PKR 183.782026-07-22 | PKR 0.18/ mL |
| Unisol -10 | Unisa Pharmaceutical Industries Limited | 10 g | IV infusion | 1000 ml | 073392 | PKR 201.272026-07-22 | PKR 0.20/ mL |
| Unisol -10 | Unisa Pharmaceutical Industries Limited | 10% | IV infusion | 500 ml | 073392 | PKR 143.532026-07-22 | PKR 0.29/ mL |
| Unisol -5 | Unisa Pharmaceutical Industries Limited | 5% | IV infusion | 500 ml | 073391 | PKR 133.022026-07-22 | PKR 0.27/ mL |
| Unisol -5 | Unisa Pharmaceutical Industries Limited | 5.0 g | IV infusion | 1000 ml | 073391 | PKR 161.012026-07-22 | PKR 0.16/ mL |
| Unisol -5 | Unisa Pharmaceutical Industries Limited | 5.0 g | IV infusion | 100 ml | 073391 | PKR 87.512026-07-22 | PKR 0.88/ mL |
| Unisol-RLD | Unisa Pharmaceutical Industries Limited | 0.02 g + 0.03 g + 0.60 g + 0.31 g + 5 g / 100 mL | IV infusion | 1000 ml | 075546 | PKR 211.782026-07-22 | PKR 0.21/ mL |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.